We are not just challenging DEA policy, we are defending the Constitution said Duane Boise, CEO of MMJ BioPharma Cultivation. The DEA cannot sidestep Supreme Court precedent and force us into a ...

The National Institute for Health and Care Excellence (NICE) has officially backed a AI tool for detecting skin cancer, marking a major milestone in the use of AI to free up specialist clinician’s ...

Aviva’s in-house capital unit that invests in a range of infrastructure and real estate projects, and mixed-use developer ...

VANCOUVER, BC / ACCESS Newswire / April 30, 2025 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality ...

TORONTO, ON / ACCESS Newswire / April 30, 2025 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") announces the resignation of Mr. Richard Yoon from its Board of Directors, ...

Company Confirms Both Acquisitions are On Track and Progressing From Signing to Closing, Reiterates Guidance of $65M+ Pro Forma RevenuesTRNR to Provide Positive Update on Sporstech Q1 2025 Performance ...

Emsculpt NEO's role in aesthetic and functional wellness will be the focus of the upcoming BODYWELLE-hosted event in Miami Beach, featuring demos and expert insights. MIAMI BEACH, FLORIDA / ACCESS ...

Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Organic (non-GAAP) 1 basis over the prior year periodGAAP Net Loss Attributable to Bausch Health Companies of $58 million ...

The next generation of professional athletes relies on the sam® wearable ultrasound unit from ZetrOZ Systems to recover ...

New collaboration brings greater access to preventive dental and coordinated medical care for aging adults across southern New Jersey. EGG HARBOR CITY, NEW JERSEY / ACCESS Newswire / April 30, 2025 / ...

European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation ...

Cycuria aims to revolutionise treatment of hard-to-treat blood cancers with a first-in-class protein-based therapeutic approach specifically targeting both tumour cells and tumour stem cells·    ...